Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis
Open accessThe DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Myofibroblasts produce the fibrous scar in hepatic fibrosis. In the carbon tetrachloride (CCl(4)) model of liver fibrosis, quiescent hepatic stellate cells (HSC) are activated to become myofibroblasts. When the underlying etiological agent is removed, clinical and experimental fibrosis undergoes a remarkable regression with complete disappearance of these myofibroblasts. Although some myofibroblasts apoptose, it is unknown whether other myofibroblasts may revert to an inactive phenotype during regression of fibrosis. We elucidated the fate of HSCs/myofibroblasts during recovery from CCl(4)- and alcohol-induced liver fibrosis using Cre-LoxP-based genetic labeling of myofibroblasts. Here we demonstrate that half of the myofibroblasts escape apoptosis during regression of liver fibrosis, down-regulate fibrogenic genes, and acquire a phenotype similar to, but distinct from, quiescent HSCs in their ability to more rapidly reactivate into myofibroblasts in response to fibrogenic stimuli and strongly contribute to liver fibrosis. Inactivation of HSCs was associated with up-regulation of the anti-apoptotic genes Hspa1a/b, which participate in the survival of HSCs in culture and in vivo.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Conversely, restored RSPO3 expression during HSC deactivation52,53 or by therapeutic interventions might help to regain hepatocyte functions.”
From Hepatic stellate cells control liver zonation, size and functions via R-spondin 3 (2025) · cites this paper as [52]
In the citing paper
“Animal models reinforce the capacity of the injured liver to regress fibrosis and provide important platform for dissecting underlying mechanisms, although it should be noted that fibrosis in mice regresses incredibly rapidly, which may be in part attributed to the short duration of models (weeks to months in mice vs. years to decades in humans) and initiation of fibrosis at relatively young age (”
From Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH) (2023) · cites this paper as [262]
In the citing paper
“Fibroblast activation also involves increased activity of key glycolytic enzymes, such as hexokinase 2 and lactate dehydrogenase (LDH)47, which in turn increase cell proliferation47 and collagen synthesis48.”
From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [47]
In the citing paper
“During enhanced glycolysis, increased amounts of pyruvate are converted to acetyl-CoA in the mitochondrial matrix47 before entering the citric acid cycle. This yields intermediate metabolites, such as succinate, which promote fibrosis49.”
From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [47]
Citations
Cites
Bataller, R., & Brenner, D. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24282 · Cited by 4,958
Self-citationSenescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027
TLR4 enhances TGF-β signaling and hepatic fibrosis
Seki, E., De Minicis, S., Österreicher, C. H., Kluwe, J., Osawa, Y., Brenner, D. A., & Schwabe, R. F. (2007) · Nature Medicine · doi:10.1038/nm1663 · Cited by 1,942
Self-citationBataller, R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524282c1 · Cited by 1,472
Iredale, J. P., Benyon, R. C., Pickering, J., McCullen, M., Northrop, M., Pawley, S., Hovell, C., & Arthur, M. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1018 · Cited by 1,075 · cited 8×
“Myofibroblasts are aSMA collagen type I cells that are absent from the normal uninjured liver, rapidly emerge infibrotic liver to produce thefibrous scar, and completely disappear with regression of liver fibrosis (1, 2).”
BackgroundInfluentialThe role of matrix stiffness in regulating cell behavior†
Wells, R. G. (2008) · Hepatology · doi:10.1002/hep.22193 · Cited by 1,059
Hepatic lipocytes: the principal collagen-producing cells of normal rat liver.
Friedman, S. L., Roll, F. J., Boyles, J., & Bissell, D. M. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.24.8681 · Cited by 859
Lee, K. S., Buck, M., Houglum, K., & Chojkier, M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118304 · Cited by 539
Ito Cells Are Liver-Resident Antigen-Presenting Cells for Activating T Cell Responses
Winau, F., Hegasy, G., Weiskirchen, R., Weber, S., Cassan, C., Sieling, P. A., Modlin, R. L., Liblau, R. S., Gressner, A. M., & Kaufmann, S. H. E. (2007) · Immunity · doi:10.1016/j.immuni.2006.11.011 · Cited by 410
Lee, C. G., Cho, S. J., Kang, M. J., Chapoval, S. P., Lee, P. J., Noble, P. W., Yehualaeshet, T., Lu, B., Flavell, R. A., Milbrandt, J., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040104 · Cited by 369
Cited by
Items 401–500 of 889
Cellular Interactions and Crosstalk Facilitating Biliary Fibrosis in Cholestasis
Ceci, L., Gaudio, E., & Kennedy, L. L. (2024) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2024.01.005 · Cited by 30
Plasticity, heterogeneity, and multifunctionality of hepatic stellate cells in liver pathophysiology
Du, K., Jun, J. H., Dutta, R. K., & Diehl, A. M. (2024) · Hepatology Communications · doi:10.1097/hc9.0000000000000411 · Cited by 31
Tashiro, K., Satoh, A., Utsumi, T., Chung, C., & Iwakiri, Y. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.11.032 · Cited by 31
You Say You Want a Resolution (of Fibrosis)
Atabai, K., Yang, C. D., & Podolsky, M. J. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2020-0182tr · Cited by 31
Activation of Cardiac Fibroblasts by Ethanol Is Blocked by TGF ‐β Inhibition
Law, B. A., & Carver, W. E. (2013) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12111 · Cited by 31
Selective targeting of endothelial and perivascular angiocrine ROCK2 treats liver fibrosis
Hu, Y., Yang, B., Xiao, C., Yang, X., Zhang, H., Yang, P., Du, X., Zhang, G., Liang, B., Bai, N., et al. (2026) · Cell · doi:10.1016/j.cell.2026.02.001 · Cited by 32
Jiang, Z., Shen, Q., Chen, H., Yang, Z., Shuai, M., & Zheng, S. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3950 · Cited by 30
Mastoridou, E. M., GOUSSIA, A. C., Glantzounis, G. K., Kanavaros, P., & Charchanti, A. V. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2021.801340 · Cited by 31
Tsukui, T., Ueha, S., Shichino, S., Inagaki, Y., & Matsushima, K. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.07.022 · Cited by 30
Kalash, R., Epperly, M. W., Goff, J. P., Dixon, T. M., Sprachman, M. M., Zhang, X., Shields, D. S., Cao, S., Franicola, D., Wipf, P., et al. (2013) · Radiation Research · doi:10.1667/rr3233.1 · Cited by 30
Myofibroblasts in Fibrotic Kidneys
Nakagawa, N., & Duffield, J. S. (2013) · Current Pathobiology Reports · doi:10.1007/s40139-013-0025-8 · Cited by 30
Li, Y., Lua, I., French, S. W., & Asahina, K. (2015) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00257.2015 · Cited by 30
Structure, Function, and Responses to Injury
Crawford, J. M., Bioulac‐Sage, P., & Hytiroglou, P. (2017) · Elsevier eBooks · doi:10.1016/b978-0-7020-6697-9.00001-7 · Cited by 29
Mechanisms of liver fibrosis in metabolic syndrome
Mehal, W. (2023) · eGastroenterology · doi:10.1136/egastro-2023-100015 · Cited by 28
“…injury, there is a functional reversion of myofibroblasts into an inactivated state which looks very much like quiescent HSC, but these cells are epigenetically and functionally different from quiescent HSC, and in response to stimuli undergo differentiation much faster than quiescent HSC. 15 16”
BackgroundSingle nucleus transcriptomics data integration recapitulates the major cell types in human liver
Diamanti, K., Inda-Díaz, J. S., Raine, A., Pan, G., Wadelius, C., & Cavalli, M. (2020) · Hepatology Research · doi:10.1111/hepr.13585 · Cited by 28
Rho-Kinase as a Therapeutic Target for Nonalcoholic Fatty Liver Diseases
Sousa‐Lima, I., Kim, H. J., Jones, J. G., & Kim, Y. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0197 · Cited by 28
Lu, C., Xu, W., Zhang, F., Shao, J., & Zheng, S. (2016) · Toxicology · doi:10.1016/j.tox.2016.07.018 · Cited by 28
Abdelnabi, M. N., Molina, M. F., Soucy, G., Trinh, V. Q., Bédard, N., Mazouz, S., Jouvet, N., Dion, J., Tran, S., Bilodeau, M., et al. (2022) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2022.08.001 · Cited by 27
Alcohol-Associated Liver Disease Outcomes: Critical Mechanisms of Liver Injury Progression
Osna, N. A., Tikhanovich, I., Ortega‐Ribera, M., Mueller, S., Zheng, C., Mueller, J. H., Li, S., Sakane, S., Weber, R. C. G., Kim, H. Y., et al. (2024) · Biomolecules · doi:10.3390/biom14040404 · Cited by 28
Self-citationTennakoon, A. H., Izawa, T., Wijesundera, K. K., Golbar, H. M., Tanaka, M., Ichikawa, C., Kuwamura, M., & Yamate, J. (2013) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2013.05.008 · Cited by 27
Early to Phase II drugs currently under investigation for the treatment of liver fibrosis
Hauff, P., Gottwald, U., & Ocker, M. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2015.997874 · Cited by 27
PTP1B confers liver fibrosis by regulating the activation of hepatic stellate cells
Chen, P., Cai, S.-P., Yang, Y., Li, W., Huang, C., Meng, X., & Li, J. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.12.021 · Cited by 28
Rodent models of fatty liver diseases
Bertola, A. (2018) · Liver Research · doi:10.1016/j.livres.2018.03.001 · Cited by 27
Valentino, G., Zivko, C., Weber, F., Brülisauer, L., & Luciani, P. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11120676 · Cited by 27
Ke, B.-J., & Lee, C.-L. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.02.010 · Cited by 27
Hyaluronic acid and tissue mechanics orchestrate mammalian digit tip regeneration
Mui, B. W. H., Wong, J. J. Y., Dumas, C. E., Wang, J. H., Bray, T., Hirose, K., Connolly, L., Winkel, A. K., Timmler, S., Bright, N. A., et al. (2026) · Science · doi:10.1126/science.ady3136 · Cited by 26
Blood Vessel Resident Human Stem Cells in Health and Disease
Craig, D. J., James, A. W., Wang, Y., Tavian, M., Crisan, M., & Péault, B. (2022) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szab001 · Cited by 26
Banerjee, A., & Farci, P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168641 · Cited by 26
Microvascular pericytes in healthy and diseased kidneys
Lin, S., Pan, S., & Chang, Y.-T. (2014) · International Journal of Nephrology and Renovascular Disease · doi:10.2147/ijnrd.s37892 · Cited by 26
Konishi, T., Schuster, R. M., & Lentsch, A. B. (2018) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00154.2018 · Cited by 27
Majeed, M. A., Majeed, S., Nagabhushanam, K., Lawrence, L., & Mundkur, L. (2020) · Scientific Reports · doi:10.1038/s41598-020-64293-w · Cited by 26
Role of cytoglobin, a novel radical scavenger, in stellate cell activation and hepatic fibrosis
Thủy, L. T. T., Hai, H., & Kawada, N. (2020) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2020.0037 · Cited by 26
Advances in the clinical use of collagen as biomarker of liver fibrosis
Meurer, S. K., Karsdal, M. A., & Weiskirchen, R. (2020) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2020.1814746 · Cited by 25
Mitochondrial folate metabolism–mediated α-linolenic acid exhaustion masks liver fibrosis resolution
Gao, Y., Zheng, B., Xu, S., Zhao, Z., Liu, W., Wang, T., Yuan, M., Sun, X., Tan, Y., Xu, Q., et al. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104909 · Cited by 25
Linking immune responses with fibrosis in allergic eye disease
Dale, S. B., & Saban, D. R. (2015) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000197 · Cited by 25
Biomimetic nanoparticles for targeted therapy of liver disease
Vijayan, V., Unagolla, J. M., Panchal, D., Okoh, J. E., Menon, S. S., & Menon, J. U. (2025) · RSC Pharmaceutics · doi:10.1039/d5pm00044k · Cited by 24
Ryzhov, S. V., Sung, B. H., Zhang, Q., Weaver, A. M., Gumina, R. J., Biaggioni, I., & Feoktistov, I. (2014) · Purinergic Signalling · doi:10.1007/s11302-014-9410-y · Cited by 24
Norambuena‐Soto, I., Núñez-Soto, C., Sanhueza‐Olivares, F., Cancino-Arenas, N., Mondaca‐Ruff, D., Vivar, R., Díaz-Araya, G., Mellado, R., & Chiong, M. (2017) · BioScience Trends · doi:10.5582/bst.2017.01017 · Cited by 24
Src-homology protein tyrosine phosphatase-1 agonist, SC-43, reduces liver fibrosis
Su, T., Shiau, C., Jao, P., Yang, N.-J., Tai, W., Liu, C., Tseng, T., Yang, H., Liu, C., Huang, K., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-01572-z · Cited by 24
Synectin promotes fibrogenesis by regulating PDGFR isoforms through distinct mechanisms
Drinane, M. C., Yaqoob, U., Yu, H., Luo, F., Greuter, T., Arab, J. P., Kostallari, E., Verma, V. K., Maiers, J. L., de Assuncao, T. M., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.92821 · Cited by 24
Self-citationManetti, M., Romano, E., Rosa, I., Fioretto, B. S., Praino, E., Guiducci, S., Iannone, F., Ibba‐Manneschi, L., & Matucci‐Cerinic, M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8081256 · Cited by 24
Guo, Q., Chen, M., Chen, Q., Xiao, G., Chen, Z., Wang, X., & Huang, Y. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370220960391 · Cited by 24
Sepúlveda‐Crespo, D., Resino, S., & Martínez, I. (2021) · Drugs · doi:10.1007/s40265-020-01458-x · Cited by 24
Animal and Human Models of Tissue Repair and Fibrosis: An Introduction
Lagares, D., & Hinz, B. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1382-5_20 · Cited by 24
Systemic inhibition of BMP1-3 decreases progression of CCl4-induced liver fibrosis in rats
Grgurević, L., Erjavec, I., Grgurević, I., Dumić-Čule, I., Brkljačić, J. M., Verbanac, D., Matijašić, M., Paljetak, H. Č., Novak, R., Plečko, M., et al. (2017) · Growth Factors · doi:10.1080/08977194.2018.1428966 · Cited by 24
Puerarin: a hepatoprotective drug from bench to bedside
He, Y.-X., Liu, M., Wu, H., Lan, Q., Liu, H., Mazhar, M., Xue, J.-Y., Zhou, X., Chen, H., & Li, Z. (2024) · Chinese Medicine · doi:10.1186/s13020-024-01011-y · Cited by 23
Newberry, E. P., Xie, Y., Lodeiro, C., Solis, R. A., Moritz, W. R., Kennedy, S., Barron, L. M., Onufer, E. J., Alpini, G. D., Zhou, T., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201801976r · Cited by 23
RSPO4-CRISPR alleviates liver injury and restores gut microbiota in a rat model of liver fibrosis
Yu, L., Wang, L., Wu, X., & Yi, H. (2021) · Communications Biology · doi:10.1038/s42003-021-01747-5 · Cited by 23
The Epigenetic Regulation of Microenvironment in Hepatocellular Carcinoma
Wang, F., Malnassy, G., & Qiu, W. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.653037 · Cited by 23
Liu, S.-X., Du, Y.-C., & Zeng, T. (2021) · Toxicology Research · doi:10.1093/toxres/tfab042 · Cited by 23
Li, Z., Zhao, L., Xia, Y., Chen, J., Mei, H., & Sun, Y. (2021) · Molecules · doi:10.3390/molecules26226882 · Cited by 24
CDH11 promotes liver fibrosis via activation of hepatic stellate cells
Ruan, W., Pan, R., Shen, X., Nie, Y., & Yayun, W. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.11.153 · Cited by 23
Retinoids in Stellate Cells: Development, Repair, and Regeneration
Carmona, R., Barrena, S., & Muñoz‐Chápuli, R. (2019) · Journal of Developmental Biology · doi:10.3390/jdb7020010 · Cited by 23
Tsuchida, T. (2019) · Folia Pharmacologica Japonica · doi:10.1254/fpj.154.203 · Cited by 23
Portal Fibroblasts in Biliary Fibrosis
Wells, R. G. (2014) · Current Pathobiology Reports · doi:10.1007/s40139-014-0054-y · Cited by 23
Tissue regeneration: Unraveling strategies for resolving pathological fibrosis
Li, J., Wang, S., Yuan, J., Mao, X., Wang, X., Zhang, L., Dong, Q., Chen, Z., Wang, Y., & Tang, N. (2025) · Cell stem cell · doi:10.1016/j.stem.2025.10.002 · Cited by 23
Troutman, T. D., Bennett, H. R., Sakai, M., Seidman, J. S., Heinz, S., & Glass, C. K. (2021) · STAR Protocols · doi:10.1016/j.xpro.2021.100363 · Cited by 22
Self-citationGou, Y., Weng, Y., Chen, Q., Wu, J., Wang, H., Zhong, J., Bi, Y., Cao, D., Zhao, P., Dong, X., et al. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10306 · Cited by 22
Zhao, J., Ghallab, A., Hassan, R. A. R. A., Dooley, S., Hengstler, J. G., & Drasdo, D. (2023) · iScience · doi:10.1016/j.isci.2023.108077 · Cited by 22
Cheng, Z., Li, F., Qie, Y., Sun, J., Wang, Y., Zhao, Y., & Nie, G. (2024) · Nano Letters · doi:10.1021/acs.nanolett.4c04820 · Cited by 22
Huang, W., Zheng, Y., Feng, H., Ni, L., Ruan, Y.-F., Zou, X., Ye, M., & Zou, S. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.109932 · Cited by 22
Blake, R. R., Markby, G. R., Culshaw, G., Pereira, Y. M., Lu, C.-C., & CORCORAN, B. M. (2019) · Research in Veterinary Science · doi:10.1016/j.rvsc.2019.11.004 · Cited by 21
Emerging role of BMPs/BMPR2 signaling pathway in treatment for pulmonary fibrosis
Ye, Q., Taleb, S. J., Zhao, J., & Zhao, Y. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117178 · Cited by 22
The elusive source of myofibroblasts: problem solved?
Duffield, J. S. (2012) · Nature Medicine · doi:10.1038/nm.2867 · Cited by 21
Manzano‐Núñez, F., Arámbul-Anthony, M. J., Albiñana, A. G., Leal‐Tassias, A., Umanzor, C. A., Gascó, I. B., Herrera, A., Vila, J. F., Burks, D. J., & Noon, L. A. (2019) · PLoS Biology · doi:10.1371/journal.pbio.2006972 · Cited by 21
Role of the S100 protein family in liver disease (Review)
Yao, S., Yang, X., An, J., Jin, H. D., Wen, G., Wang, H., & Tuo, B. (2021) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2021.4999 · Cited by 21
Epimorphin Alters the Inhibitory Effects of SOX9 on Mmp13 in Activated Hepatic Stellate Cells
Pritchett, J. P., Athwal, V. S., Harvey, E., Martin, K., Llewellyn, J., Ireland, P., Nicolaides, A., Humphries, M. J., Bobola, N., Hanley, N. A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100091 · Cited by 21
Hepatocellular carcinoma: Mouse models and the potential roles of proteases
Henderson, J. M., Zhang, H. E., Polak, N., & Gorrell, M. D. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.03.047 · Cited by 21
Furuya, S., Chappell, G. A., Iwata, Y., Uehara, T., Kato, Y., Kono, H., Bataller, R. A., & Rusyn, I. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.09.011 · Cited by 21
P311, Friend, or Foe of Tissue Fibrosis?
Stradiot, L., Mannaerts, I., & van Grunsven, L. A. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01151 · Cited by 21
Fibroblasts as regulators of lung immunity, repair and fibrosis
Bell, P. T., & Belz, G. T. (2026) · Nature reviews. Immunology · doi:10.1038/s41577-026-01268-4 · Cited by 22
Romano, V., Ruocco, M. R., Carotenuto, P., Barbato, A., Venuta, A., Acampora, V., Lella, S. D., Vigliar, E., Iaccarino, A., Troncone, G., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126875 · Cited by 20
Ezhilarasan, D., & Najimi, M. (2023) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2022.103902 · Cited by 20
Wan, G., Chen, Z., Lei, L., Geng, X., Zhang, Y., Yang, C., Cao, W., & Pan, Z. (2023) · Chinese Medicine · doi:10.1186/s13020-023-00723-x · Cited by 20
Schonfeld, M. P., O’Neil, M. F., Weinman, S. A., & Tikhanovich, I. (2023) · Hepatology · doi:10.1097/hep.0000000000000675 · Cited by 21
Effects of embryonic origin, tissue cues and pathological signals on fibroblast diversity in humans
Torregrossa, M., Davies, L. C., Machens, H., Simon, J. C., Franz, S., & Rinkevich, Y. (2025) · Nature Cell Biology · doi:10.1038/s41556-025-01638-5 · Cited by 20
TGF-β–Dependent Dendritic Cell Chemokinesis in Murine Models of Airway Disease
Hashimoto, M., Yanagisawa, H., Minagawa, S., Sen, D., Ma, R., Murray, L. A., Tsui, P., Lou, J., Marks, J. D., Baron, J. L., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500348 · Cited by 20
Inhibitory effect of dietary capsaicin on liver fibrosis in mice
Bitencourt, S., Stradiot, L., Verhulst, S., Thoen, L. F. R., Mannaerts, I., & van Grunsven, L. A. (2015) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201400649 · Cited by 20
Strategies to Detect Hepatic Myofibroblasts in Liver Cirrhosis of Different Etiologies
Iwaisako, K., Taura, K., Koyama, Y., Takemoto, K., & Asagiri, M. (2014) · Current Pathobiology Reports · doi:10.1007/s40139-014-0057-8 · Cited by 21
Self-citationStellate Cells and Hepatic Fibrosis
Hasegawa, D., Wallace, M. C., & Friedman, S. L. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800134-9.00004-x · Cited by 21
Li, Z. X., Sheng, X. D., Wang, Y. L., & Lv, X. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109326 · Cited by 20
Biomarkers of liver fibrosis detecting with electrochemical immunosensor on clinical serum
Yao, Y., Bao, J., Lu, Y., Zhang, D., Luo, S., Cheng, X., Zhang, Q. Y., Li, S., & Liu, Q. (2015) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2015.08.064 · Cited by 20
Baligar, P., Mukherjee, S., Kochat, V., Rastogi, A., & Mukhopadhyay, A. (2015) · Stem Cells · doi:10.1002/stem.2210 · Cited by 20
Mechanisms involved in liver damage resolution after hepatitis C virus clearance
SALAS-VILLALOBOS, T. B., Lozano-Sepúlveda, S. A., Rincón‐Sánchez, A. R., Govea‐Salas, M., & Rivas, A. (2017) · Medicina Universitaria · doi:10.1016/j.rmu.2017.05.005 · Cited by 20
Wu, D., Rao, Q., Chen, W., Ji, F., Xie, Z., Huang, K., Chen, E., Zhao, Y., Ouyang, X., Zhang, S., et al. (2018) · Liver International · doi:10.1111/liv.13756 · Cited by 20
AMPK stimulation inhibits YAP/TAZ signaling to ameliorate hepatic fibrosis
Shihan, M. H., Sharma, S. K., Cable, C., Prathigudupu, V., Chen, A. J., Mattis, A. N., & Chen, J. Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-55764-5 · Cited by 19
Sokal-Dembowska, A., Jarmakiewicz-Czaja, S., Ferenc, K., & Filip, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105238 · Cited by 19
Bouguéon, M., Legagneux, V., Hazard, O., Bomo, J., Siegel, A., Ferêt, J., & Théret, N. (2024) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1011858 · Cited by 19
Avagliano, A., Ruocco, M. R., Nasso, R., Aliotta, F., Sanità, G., Iaccarino, A., Bellevicine, C., Calì, G., Fiume, G., Masone, S., et al. (2019) · Cells · doi:10.3390/cells8111435 · Cited by 19
Organelle stress and alterations in interorganelle crosstalk during liver fibrosis
Sinha, S., Hassan, N. A., & Schwartz, R. E. (2023) · Hepatology · doi:10.1097/hep.0000000000000012 · Cited by 19
Homing in on the hepatic scar: recent advances in cell-specific targeting of liver fibrosis
Dobie, R., & Henderson, N. C. (2016) · F1000Research · doi:10.12688/f1000research.8822.1 · Cited by 18
Hepatic Stellate Cells Functional Heterogeneity in Liver Cancer
Sererols-Viñas, L., Garcia‐Vicién, G., Ruiz-Blázquez, P., Lee, T., Lee, Y. A., Gonzalez‐Sanchez, E., Vaquero, J., Moles, A., Filliol, A. A., & Affò, S. (2025) · Seminars in Liver Disease · doi:10.1055/a-2551-0724 · Cited by 18
Zhang, H., Zhou, P., Xing, W., Chen, L., Zhou, Y., Yang, H., Fu, K., & Liu, Z. (2022) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2022.10.015 · Cited by 18
Li, L., Diao, S., Chen, Z., Zhang, J., Chen, W. J., Wang, T., Chen, X., Zhao, Y., Xu, T., Huang, C., et al. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106808 · Cited by 18
Kocabayoglu, P., Zhang, D. Y., Kojima, K., Hoshida, Y., & Friedman, S. L. (2015) · Liver International · doi:10.1111/liv.12933 · Cited by 18
Fernández, M. C., Rayes, R. F., Ham, B., Wang, N., Bourdeau, F., Milette, S., lllemann, M., Bird, N. C., Majeed, A. W., Xu, J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12595 · Cited by 18
Varma, S., Stéphenne, X., Komuta, M., Bouzin, C., Ambroise, J., Smets, F. N., Reding, R., & Sokal, E. M. (2016) · Pediatric Transplantation · doi:10.1111/petr.12834 · Cited by 18
Reversion of in vivo fibrogenesis by novel chromone scaffolds
Kim, H.-S., Yoon, Y.-M., Meang, M. K., Park, Y. E., Lee, J. Y., Lee, T. H., Lee, J. E., Kim, I. H., & Youn, B. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2018.12.017 · Cited by 18
Petrescu, A. D., Grant, S. M., Frampton, G. A., McMillin, M., Kain, J., Kodali, M., Shetty, A. K., & DeMorrow, S. (2018) · Scientific Reports · doi:10.1038/s41598-018-31599-9 · Cited by 18
Organ fibrosis: beyond collagen I expression. Fibroblast phenotype and basement membrane proteins
Biggs, R. M., & Bradshaw, A. D. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00077.2025 · Cited by 17
Metadata
- Authors
- Kisseleva, T., Cong, M., Paik, Y., Scholten, D., Jiang, C., Benner, C., Iwaisako, K., Moore-Morris, T., Scott, B., Tsukamoto, H., Evans, S. M., Dillmann, W., Glass, C. K., & Brenner, D. A.
- Affiliations
- Department of Medicine,
- Universitätsklinikum Aachen (DE)
- Department of Cellular and Molecular Medicine,
- School of Pharmacy, University of California, San Diego, CA 92093;
- University of Southern California (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2012-05-07
- Volume
- 109
- Issue
- 24
- Pages
- 9448-9453
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC3386114
- OpenAlex
- W2075290880
- Cited by
- 805
- References
- 27
- Citations by year
- 2026: 29 · 2025: 51 · 2024: 61 · 2023: 59 · 2022: 53 · 2021: 62 · 2020: 64 · 2019: 52 · 2018: 53 · 2017: 61 · 2016: 64 · 2015: 73 · 2014: 63 · 2013: 42 · 2012: 13
- FWCI
- 38.69
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- RWTH Publications (RWTH Aachen) (submittedVersion)
- Funders
- National Institute of General Medical Sciences (R01GM041804)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Keywords
- myofibroblasts, hepatic stellate cells, liver fibrosis, fibrosis regression, apoptosis, anti-apoptotic genes, carbon tetrachloride, alcohol-induced liver injury, fibrogenic gene expression
- MeSH terms
- Animals, Liver Cirrhosis, Phenotype, Tamoxifen, Adoptive Transfer, Collagen Type I, Mice, Myofibroblasts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.